Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Merck Near A Deal To Buy Acceleron Pharma

-Dow Jones

byBenzinga Newsdesk

September 27, 2021

1 minute read

-Dow Jones

Eltek Q3 EPS $0.17, Sales $10.30M Up From $7.96M YoY

By Benzinga Newsdesk

Today, 3:04 AM

Eltek (NASDAQ:ELTK) reported quarterly earnings of $0.17 per share. The company reported $10.30 million in sales this quarter. This is a 29.32 percent increase over sales of $7.96 million the same period last year.

ELTK

Barclays Maintains Overweight on CrowdStrike Holdings, Lowers Price Target to $182

By Benzinga Newsdesk

Today, 3:04 AM

Barclays analyst Saket Kalia maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Overweight and lowers the price target from $255 to $182.

CRWD

News

Paramount Receives Permit To Drill Bald Peak Project In Mineral County, Nevada

By Benzinga Newsdesk

Today, 3:04 AM

Paramount Gold Nevada Corp. (NYSE:PZG) ("Paramount" or the "Company") announced today that it has received the permit from the US Forest Service to drill its Bald Peak Project ("Bald Peak")

PZG

Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Portage Biotech Shares Slide

By Lisa Levin

Today, 3:04 AM

Toward the end of trading Thursday, the Dow traded up 1.03% to 34,222.59 while the NASDAQ rose 0.74% to 14,377.16. The S&P also rose, gaining 0.67% to 4,270.15.

ACN

Merck Near A Deal To Buy Acceleron Pharma

Related Posts

Eltek Q3 EPS $0.17, Sales $10.30M Up From $7.96M YoY

Barclays Maintains Overweight on CrowdStrike Holdings, Lowers Price Target to $182

Paramount Receives Permit To Drill Bald Peak Project In Mineral County, Nevada

Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Portage Biotech Shares Slide